SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 77502.12
579.48 (0.75%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Health X Platform Ltd.	Q V PT	1,009 Small Cap	311 (-1.91%)	N/A	3.65	109.54	-201.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Fischer Medical Ventures Ltd.	Q V PT	2,681 Small Cap	39.08 (-4.59%)	N/A	8.19	96.10	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	3B Blackbio Dx Ltd.	Q V PT	1,028 Small Cap	1,207.75 (0.84%)	21.02	3.8	46.29	132.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Max Healthcare Institute Ltd.	Q V+ PT	1,10,950 Mid Cap	1,127.45 (-1.10%)	76.07	10.21	46.01	60.18	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Indegene Ltd.	Q V+ PT	12,364 Small Cap	514.60 (0.26%)	30.91	3.95	34.59	31.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Acutaas Chemicals Ltd.	Q V+ PT	29,259 Small Cap	3,690.15 (3.26%)	82.51	18.11	32.80	16.82	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Rubicon Research Ltd.	Q V+ PT	22,613 Small Cap	1,374.55 (0.53%)	120.81	16.8	32.49	25.95	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Yatharth Hospital & Trauma Care Services Ltd.	Q V PT	8,257 Small Cap	862.80 (0.68%)	87.13	5.13	27.90	137.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Dr. Agarwals Health Care Ltd.	Q V PT	14,873 Small Cap	476.35 (1.52%)	113.37	7.45	26.38	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Innova Captab Ltd.	Q V PT	5,575 Small Cap	979.40 (0.54%)	66.97	6.32	25.90	14.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Sigachi Industries Ltd.	Q V+ PT	896 Small Cap	23 (-1.96%)	N/A	1.85	24.05	7.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Anthem Biosciences Ltd.	Q V PT	42,995 Mid Cap	771.30 (1.07%)	64.8	13.64	23.81	40.64	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Marksans Pharma Ltd.	Q V+ PT	12,177 Small Cap	267.05 (-0.61%)	40.25	7.32	22.06	32.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Eris Lifesciences Ltd.	Q V PT	20,028 Small Cap	1,447.25 (0.14%)	32.37	5.14	21.92	3.58	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Kwality Pharmaceuticals Ltd.	Q V+ PT	2,806 Small Cap	2,724.15 (0.72%)	41.97	8.5	21.70	37.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Jupiter Life Line Hospitals Ltd.	Q V PT	9,475 Small Cap	1,453.15 (0.55%)	49.78	5.93	21.03	54.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Poly Medicure Ltd.	Q V PT	16,876 Small Cap	1,737.80 (4.38%)	52.43	5.77	19.91	26.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	CORONA Remedies Ltd.	Q V+ PT	11,991 Small Cap	2,009 (2.47%)	66.47	16.47	19.49	18.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	KMC Speciality Hospitals (India) Ltd.	Q V PT	2,294 Small Cap	133.60 (-5.01%)	N/A	N/A	19.21	12.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Concord Biotech Ltd.	Q V PT	13,461 Small Cap	1,284.25 (-0.19%)	51.49	6.66	18.56	18.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Natco Pharma Ltd.	Q V PT	16,570 Small Cap	933.80 (0.93%)	11.79	1.81	18.26	32.57	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Windlas Biotech Ltd.	Q V PT	1,779 Small Cap	861.40 (-0.05%)	26.76	3.33	18.24	17.22	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Sai Life Sciences Ltd.	Q V+ PT	26,385 Small Cap	1,238.15 (-0.38%)	76.97	10.48	17.75	11.20	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Dr Agarwals Eye Hospital Ltd.	Q V PT	2,430 Small Cap	5,105.95 (1.56%)	35.2	7.13	17.68	31.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Syncom Formulations (India) Ltd.	Q V PT	1,355 Small Cap	14.25 (-1.18%)	17.62	3.25	17.63	21.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Caplin Point Laboratories Ltd.	Q V PT	19,475 Small Cap	2,547.20 (-0.58%)	30.19	5.4	17.55	21.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Supriya Lifescience Ltd.	Q V+ PT	8,123 Small Cap	994.55 (-1.46%)	38.28	6.68	17.45	18.30	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Global Health Ltd.	Q V PT	35,695 Small Cap	1,345.50 (1.35%)	72.91	9	16.83	34.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Gufic Biosciences Ltd.	Q V PT	3,954 Small Cap	385.40 (-2.24%)	61.2	5.82	16.69	24.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Anuh Pharma Ltd.	Q V PT	802 Small Cap	81.49 (1.88%)	19.9	2.32	16.60	20.73	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Suven Life Sciences	298.65	8.92%
Themis Medicare	119.15	7.73%
Dishman Carbogen Amc	188	7%
Shilpa Medicare	600.85	5.26%
GPT Healthcare	156.45	4.40%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
KMC Speciality Hosp.	133.60	-5.01%
Morepen Laboratories	59.71	-4.63%
Fischer Medical	39.08	-4.59%
Shree Ganesh Remed.	642.40	-4.38%
Gufic Biosciences	385.40	-2.24%

News about Top Pharma Companies in India

Jul, 2026

Windlas Biotech submits AGM notice

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) read with Schedule III of the said Regulations, Windlas Biotech has informed that it enclosed a copy of the Notice of the 25th Annual General Meeting (AGM) of the Company scheduled to be held on Thursday, July 23, 2026 at 01.00 PM (IST) through Video Conferencing (VC)/Other Audio ,Visual Means (OAVM), in accordance with the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. ln compliance with the provisions of Section 108 of the Companies Act, 2013 read with Rule 20 of the Companies (Management and Administration) Rules, 2014 and Regulation 44 of the Listing Regulations, the Company is pleased to provide to its Members, facility to exercise their right to vote at the 25th AGM scheduled to be held on July 23, 2026, by electronic means and the business mentioned in the AGM Notice may be transacted through e-voting services provided by MUFG Intime India at https://instavote.linkintime.co.in/. The Company has fixed July 16, 2026 as the ‘cut-off date’ for ascertaining the names of members, holding shares of the Company, who will be entitled to cast their votes electronically during July 20, 2026 (9:00 AM) to July 22, 2026 (5:00 PM) and also during AGM in respect of business to be transacted at the aforesaid AGM and for the purpose of receiving dividend, if any.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Concord Biotech gains on clearing PPB Kenya, NDA Uganda inspection at Unit-II formulation facility

The inspection took place from June 18, 2026 to June 24, 2026, and was concluded successfully

Jun, 2026

Concord Biotech clears PPB Kenya, NDA Uganda inspection at Unit-II formulation facility

The inspection took place from June 18, 2026 to June 24, 2026, and was concluded successfully

Jun, 2026

Jupiter Life Line Hospitals informs about AGM

Jupiter Life Line Hospitals has informed that 24 th Annual General Meeting of the Company will be held on Friday, July 17, 2026 at 11:00 A.M. IST through Video Conferencing/ Other Audio Visual Means (VC/ OAVM). Enclosed copy of the Annual Report for the Financial Year 2025-26, which is being sent through electronic mode to the Members, who have registered their e-mail addresses with the Company/ Registrar and Transfer Agent/ Depositories. In addition, pursuant to Regulation 36(1)(b) of the SEBI Listing Regulations, a letter is also being sent to those Members whose email address are not registered, providing the web-link, where the Annual Report is uploaded on the website of the Company. The Annual Report will also be made available on the website of the Company at www.jupiterhospital.com

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Acutaas Chemicals informs about disclosures

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to intimation dated June 22, 2026, Acutaas Chemicals has informed that the Central Goods & Service Tax & Central Excise (CGST & CE), Anti -evasion Department, Surat, Guijarat have concluded their Inspection/Search on June 23, 2026. The details required to be disclosed under the Listing Regulations read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026 are enclosed to this letter as Annexure A.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Poly Medicure submits intimation for schedule of investor meet

Pursuant to Regulation 30 and applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III Part A, Poly Medicure has informed that the Company's officials will hold one-on-one meeting with analyst/investor on Thursday, 25th June 2026.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Health X Platform Ltd.	1,009 Crore
2	Fischer Medical Ventures Ltd.	2,681 Crore
3	3B Blackbio Dx Ltd.	1,028 Crore
4	Max Healthcare Institute Ltd.	1,10,950 Crore
5	Indegene Ltd.	12,364 Crore
6	Acutaas Chemicals Ltd.	29,259 Crore
7	Rubicon Research Ltd.	22,613 Crore
8	Yatharth Hospital & Trauma Care Services Ltd.	8,257 Crore
9	Dr. Agarwals Health Care Ltd.	14,873 Crore
10	Innova Captab Ltd.	5,575 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,722	54,328	35.00	11.38	23.88	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,663	1,57,093	72.61	18.73	38.24	29.04
Ajanta Pharma Ltd. (M)	Very Good	3,344	41,813	39.60	9.24	26.75	25.35
Lupin Ltd. (M)	Somewhat Good	2,399	1,09,576	20.55	4.88	11.89	20.83
Zydus Lifesciences Ltd. (M)	Very Good	1,100	1,10,608	21.95	4.25	13.46	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,525	80,692	101
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,318	36,871	41.28
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,663	1,57,093	39.25
Aurobindo Pharma Ltd. (M)	Very Good	1,560	89,345	34.75
Ajanta Pharma Ltd. (M)	Very Good	3,344	41,813	31.18
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,318	36,871	54.70	9.13	33.13	15.51
Mankind Pharma Ltd. (M)	Very Good	2,487	1,02,844	50.47	6.27	31.70	14.65
Ajanta Pharma Ltd. (M)	Very Good	3,344	41,813	39.60	9.24	26.75	13.54
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,346	1,11,792	26.64	2.95	14.87	13.26
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,663	1,57,093	72.61	18.73	38.24	11.80

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	1,100	1,10,608	21.95	4.25	13.46	30.57
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,872	4,47,704	39.00	5.36	22.34	23.50
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,346	1,11,792	26.64	2.95	14.87	22.29
Abbott India Ltd. (M)	Very Good	25,722	54,328	35.00	11.38	23.88	18.78
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,195	60,890	44.71	5.79	11.86	14.41

You have 9 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Windlas Biotech submits AGM notice

Concord Biotech gains on clearing PPB Kenya, NDA Uganda inspection at Unit-II formulation facility

Concord Biotech clears PPB Kenya, NDA Uganda inspection at Unit-II formulation facility

Jupiter Life Line Hospitals informs about AGM

Acutaas Chemicals informs about disclosures

Poly Medicure submits intimation for schedule of investor meet

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.